Extended amplification in vitro and replicative senescence: key factors implicated in the success of human myoblast transplantation

• Published in: Human gene therapy Vol. 14; no. 12; p. 1169
• Main Authors: Cooper, R N, Thiesson, D, Furling, D, Di Santo, J P, Butler-Browne, G S, Mouly, V
• Format: Journal Article
• Language: English
• Published: United States 10-08-2003
• Subjects: Adolescent; Aged; Animals; Cell Division; Cells, Cultured; Cellular Senescence - physiology; Female; Fluorescent Antibody Technique; Graft Rejection - immunology; Humans; Infant, Newborn; Male; Mice; Muscle Fibers, Skeletal - cytology; Muscle Proteins - analysis; Muscle Proteins - immunology; Muscle, Skeletal - chemistry; Muscle, Skeletal - cytology; Regeneration; Satellite Cells, Skeletal Muscle - transplantation
• ISSN: 1043-0342
• DOI: 10.1089/104303403322168000

The limited success of human myoblast transplantation has been related to immune rejection, poor survival, and limited spread of injected myoblasts after transplantation. An important issue that has received little attention, but is nevertheless of fundamental importance in myoblast transplantation protocols, is the proliferative capacity of human satellite cells. Previous studies from our laboratory have demonstrated that the maximum number of divisions that a population of satellite cells can make decreases with age during the first two decades of life then stabilizes in adulthood. These observations indicate that when satellite cells are used as vectors in myoblast transplantation protocols it is important to consider donor age and the number of divisions that the cells have made prior to transplantation as limiting factors in obtaining an optimal number of donor derived muscle fibers. In this study, myoblasts derived from donors of different ages (newborn, 17 years old, and 71 years old) were isolated and amplified in culture. Their potential to participate in in vivo muscle regeneration in RAG2(-/-)/gamma(c)/C5 triple immunodeficient hosts after implantation was evaluated at 4 and 8 weeks postimplantation. Our results demonstrate that prolonged amplification in culture and the approach to replicative senescence are both important factors that may condition the success of myoblast transplantation protocols.